This report aims to provide a comprehensive presentation of the global market for Diabetes Therapy and Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Therapy and Drug Delivery. This report contains market size and forecasts of Diabetes Therapy and Drug Delivery in global, including the following market information:
Global Diabetes Therapy and Drug Delivery Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Therapy and Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Inhalable Insulin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Therapy and Drug Delivery include Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind, Enteris BioPharma, Dexcom, Senseonics Holding and Medtech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Therapy and Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Therapy and Drug Delivery Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Diabetes Therapy and Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Global Diabetes Therapy and Drug Delivery Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Diabetes Therapy and Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Diagnostic/Clinics
ICUs
Home Healthcare
Global Diabetes Therapy and Drug Delivery Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Diabetes Therapy and Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Therapy and Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Therapy and Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind
Enteris BioPharma
Dexcom
Senseonics Holding
Medtech
Johnson & Johnson
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly
Transdermal Specialties
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Therapy and Drug Delivery, market overview.
Chapter 2: Global Diabetes Therapy and Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Diabetes Therapy and Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Therapy and Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Therapy and Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Therapy and Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Therapy and Drug Delivery Overall Market Size
2.1 Global Diabetes Therapy and Drug Delivery Market Size: 2022 VS 2032
2.2 Global Diabetes Therapy and Drug Delivery Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Therapy and Drug Delivery Players in Global Market
3.2 Top Global Diabetes Therapy and Drug Delivery Companies Ranked by Revenue
3.3 Global Diabetes Therapy and Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Therapy and Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetes Therapy and Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Therapy and Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Therapy and Drug Delivery Market Size Markets, 2022 & 2032
4.1.2 Inhalable Insulin
4.1.3 Oral Insulin
4.1.4 Insulin Patches
4.1.5 CGM Systems
4.1.6 Artificial Pancreas
4.2 By Type - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Diabetes Therapy and Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Therapy and Drug Delivery Revenue, 2024-2032
4.2.3 By Type - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Therapy and Drug Delivery Market Size, 2022 & 2032
5.1.2 Diagnostic/Clinics
5.1.3 ICUs
5.1.4 Home Healthcare
5.2 By Application - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Diabetes Therapy and Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Therapy and Drug Delivery Revenue, 2024-2032
5.2.3 By Application - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Diabetes Therapy and Drug Delivery Market Size, 2022 & 2032
6.2 By Region - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Diabetes Therapy and Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Therapy and Drug Delivery Revenue, 2024-2032
6.2.3 By Region - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Diabetes Therapy and Drug Delivery Revenue, 2018-2032
6.3.2 US Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.3.3 Canada Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.3.4 Mexico Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Diabetes Therapy and Drug Delivery Revenue, 2018-2032
6.4.2 Germany Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.4.3 France Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.4.4 U.K. Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.4.5 Italy Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.4.6 Russia Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.4.7 Nordic Countries Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.4.8 Benelux Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Diabetes Therapy and Drug Delivery Revenue, 2018-2032
6.5.2 China Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.5.3 Japan Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.5.4 South Korea Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.5.5 Southeast Asia Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.5.6 India Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Diabetes Therapy and Drug Delivery Revenue, 2018-2032
6.6.2 Brazil Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.6.3 Argentina Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue, 2018-2032
6.7.2 Turkey Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.7.3 Israel Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.7.4 Saudi Arabia Diabetes Therapy and Drug Delivery Market Size, 2018-2032
6.7.5 UAE Diabetes Therapy and Drug Delivery Market Size, 2018-2032
7 Diabetes Therapy and Drug Delivery Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Major Product Offerings
7.1.4 Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Medtronic
7.2.1 Medtronic Company Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Diabetes Therapy and Drug Delivery Major Product Offerings
7.2.4 Medtronic Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Medtronic Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Diabetes Therapy and Drug Delivery Major Product Offerings
7.3.4 Sanofi Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Major Product Offerings
7.4.4 Novo Nordisk Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 MannKind
7.5.1 MannKind Company Summary
7.5.2 MannKind Business Overview
7.5.3 MannKind Diabetes Therapy and Drug Delivery Major Product Offerings
7.5.4 MannKind Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 MannKind Key News & Latest Developments
7.6 Enteris BioPharma
7.6.1 Enteris BioPharma Company Summary
7.6.2 Enteris BioPharma Business Overview
7.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Major Product Offerings
7.6.4 Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Enteris BioPharma Key News & Latest Developments
7.7 Dexcom
7.7.1 Dexcom Company Summary
7.7.2 Dexcom Business Overview
7.7.3 Dexcom Diabetes Therapy and Drug Delivery Major Product Offerings
7.7.4 Dexcom Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Dexcom Key News & Latest Developments
7.8 Senseonics Holding
7.8.1 Senseonics Holding Company Summary
7.8.2 Senseonics Holding Business Overview
7.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Major Product Offerings
7.8.4 Senseonics Holding Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Senseonics Holding Key News & Latest Developments
7.9 Medtech
7.9.1 Medtech Company Summary
7.9.2 Medtech Business Overview
7.9.3 Medtech Diabetes Therapy and Drug Delivery Major Product Offerings
7.9.4 Medtech Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 Medtech Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Major Product Offerings
7.10.4 Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 Synertech
7.11.1 Synertech Company Summary
7.11.2 Synertech Business Overview
7.11.3 Synertech Diabetes Therapy and Drug Delivery Major Product Offerings
7.11.4 Synertech Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.11.5 Synertech Key News & Latest Developments
7.12 Zosano Pharma
7.12.1 Zosano Pharma Company Summary
7.12.2 Zosano Pharma Business Overview
7.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Major Product Offerings
7.12.4 Zosano Pharma Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.12.5 Zosano Pharma Key News & Latest Developments
7.13 Relmada Therapeutics
7.13.1 Relmada Therapeutics Company Summary
7.13.2 Relmada Therapeutics Business Overview
7.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Major Product Offerings
7.13.4 Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.13.5 Relmada Therapeutics Key News & Latest Developments
7.14 Eli Lilly
7.14.1 Eli Lilly Company Summary
7.14.2 Eli Lilly Business Overview
7.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Major Product Offerings
7.14.4 Eli Lilly Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.14.5 Eli Lilly Key News & Latest Developments
7.15 Transdermal Specialties
7.15.1 Transdermal Specialties Company Summary
7.15.2 Transdermal Specialties Business Overview
7.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Major Product Offerings
7.15.4 Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue in Global Market (2018-2023)
7.15.5 Transdermal Specialties Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Therapy and Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Diabetes Therapy and Drug Delivery Market Drivers in Global Market
Table 3. Diabetes Therapy and Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Diabetes Therapy and Drug Delivery in Global Market
Table 5. Top Diabetes Therapy and Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetes Therapy and Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetes Therapy and Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetes Therapy and Drug Delivery Product Type
Table 9. List of Global Tier 1 Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Diabetes Therapy and Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetes Therapy and Drug Delivery Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Diabetes Therapy and Drug Delivery Product Offerings
Table 32. Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Medtronic Company Summary
Table 35. Medtronic Diabetes Therapy and Drug Delivery Product Offerings
Table 36. Medtronic Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Medtronic Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Diabetes Therapy and Drug Delivery Product Offerings
Table 40. Sanofi Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Novo Nordisk Company Summary
Table 43. Novo Nordisk Diabetes Therapy and Drug Delivery Product Offerings
Table 44. Novo Nordisk Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Novo Nordisk Key News & Latest Developments
Table 46. MannKind Company Summary
Table 47. MannKind Diabetes Therapy and Drug Delivery Product Offerings
Table 48. MannKind Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. MannKind Key News & Latest Developments
Table 50. Enteris BioPharma Company Summary
Table 51. Enteris BioPharma Diabetes Therapy and Drug Delivery Product Offerings
Table 52. Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Enteris BioPharma Key News & Latest Developments
Table 54. Dexcom Company Summary
Table 55. Dexcom Diabetes Therapy and Drug Delivery Product Offerings
Table 56. Dexcom Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Dexcom Key News & Latest Developments
Table 58. Senseonics Holding Company Summary
Table 59. Senseonics Holding Diabetes Therapy and Drug Delivery Product Offerings
Table 60. Senseonics Holding Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Senseonics Holding Key News & Latest Developments
Table 62. Medtech Company Summary
Table 63. Medtech Diabetes Therapy and Drug Delivery Product Offerings
Table 64. Medtech Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. Medtech Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Diabetes Therapy and Drug Delivery Product Offerings
Table 68. Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Synertech Company Summary
Table 71. Synertech Diabetes Therapy and Drug Delivery Product Offerings
Table 72. Synertech Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 73. Synertech Key News & Latest Developments
Table 74. Zosano Pharma Company Summary
Table 75. Zosano Pharma Diabetes Therapy and Drug Delivery Product Offerings
Table 76. Zosano Pharma Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 77. Zosano Pharma Key News & Latest Developments
Table 78. Relmada Therapeutics Company Summary
Table 79. Relmada Therapeutics Diabetes Therapy and Drug Delivery Product Offerings
Table 80. Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 81. Relmada Therapeutics Key News & Latest Developments
Table 82. Eli Lilly Company Summary
Table 83. Eli Lilly Diabetes Therapy and Drug Delivery Product Offerings
Table 84. Eli Lilly Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 85. Eli Lilly Key News & Latest Developments
Table 86. Transdermal Specialties Company Summary
Table 87. Transdermal Specialties Diabetes Therapy and Drug Delivery Product Offerings
Table 88. Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 89. Transdermal Specialties Key News & Latest Developments
List of Figures
Figure 1. Diabetes Therapy and Drug Delivery Segment by Type in 2022
Figure 2. Diabetes Therapy and Drug Delivery Segment by Application in 2022
Figure 3. Global Diabetes Therapy and Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Therapy and Drug Delivery Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Diabetes Therapy and Drug Delivery Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Therapy and Drug Delivery Revenue in 2022
Figure 8. By Type - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 9. By Application - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 10. By Type - Global Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 12. By Application - Global Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 14. By Region - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 15. By Country - North America Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 16. US Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 20. Germany Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 21. France Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 28. China Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 32. India Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 34. Brazil Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue Market Share, 2018-2032
Figure 37. Turkey Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 41. Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Medtronic Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novo Nordisk Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. MannKind Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dexcom Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Senseonics Holding Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Medtech Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Synertech Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Zosano Pharma Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Eli Lilly Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
